StockData
Clene Inc. logo

Clene Inc. (CLNN) stock

CLNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$3.66−0.26 (-6.63%)

Close on Nov 16, 2026Market cap $47.03MP/E –Yield –

Clene total assets

Total assets on the balance sheet at the end of each period.

Clene's total assets was $23.04M at Jun 30, 2026. For fiscal 2025 it was $18.13M, down 33.7% from the year before. The highest annual figure on record is $68.24M in fiscal 2020.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$18.13M-33.7%
FY2024Dec 31, 2024$27.34M-47.8%
FY2023Dec 31, 2023$52.34M+17.6%
FY2022Dec 31, 2022$44.49M-29.4%
FY2021Dec 31, 2021$63.06M-7.6%
FY2020Dec 31, 2020$68.24M+358.7%
FY2019Dec 31, 2019$14.88M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$23.04M+4.1%
Q1 FY2026Mar 31, 2026$21.67M-14.4%
Q4 FY2025Dec 31, 2025$18.13M-33.7%
Q3 FY2025Sep 30, 2025$22.31M-29.3%
Q2 FY2025Jun 30, 2025$22.13M-45.1%
Q1 FY2025Mar 31, 2025$25.31M-43.8%
Q4 FY2024Dec 31, 2024$27.34M-47.8%
Q3 FY2024Sep 30, 2024$31.57M-47.8%
Q2 FY2024Jun 30, 2024$40.33M-40.6%
Q1 FY2024Mar 31, 2024$45.07M+13.0%
Q4 FY2023Dec 31, 2023$52.34M+17.6%
Q3 FY2023Sep 30, 2023$60.43M+35.7%
Q2 FY2023Jun 30, 2023$67.85M+27.1%
Q1 FY2023Mar 31, 2023$39.89M-36.7%
Q4 FY2022Dec 31, 2022$44.49M-39.1%
Q2 FY2022Jun 30, 2022$44.54M-39.2%
Q1 FY2022Mar 31, 2022$53.36M-8.8%
Q4 FY2021Dec 31, 2021$63.06M-7.6%
Q3 FY2021Sep 30, 2021$73.04M+390.9%
Q2 FY2021Jun 30, 2021$73.28M–
Q1 FY2021Mar 31, 2021$58.53M–
Q4 FY2020Dec 31, 2020$68.24M–
Q4 FY2019Dec 31, 2019$14.88M–

More Clene figures

See a number that looks wrong?